Foghorn Therapeutics Inc (FHTX) earnings · rev $30.9M
These earnings events as JSON? API free 100/dayFoghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
This FHTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FHTX revenue for 2025-12-31 was $30.9M. Net income was -$74.3M. Revenue was up 36.8% from 2024-12-31 to 2025-12-31. FHTX currently screens at market cap $237.8M.
When the next FHTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 36.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FHTX research stays on the stock page; the tape stays on the quote page.
FHTX earnings FAQ
What are FHTX's latest revenue and net income?
Latest cached Foghorn Therapeutics Inc (FHTX) revenue for Dec 31, 2025 was $30.9M. Net income was -$74.3M. Statements: https://lician.com/financials/fhtx
What is FHTX's latest diluted EPS?
Latest cached Foghorn Therapeutics Inc (FHTX) diluted EPS for Dec 31, 2025 was -$1.18.
What period does the latest FHTX earnings print cover?
The latest cached Foghorn Therapeutics Inc (FHTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did FHTX revenue change from the prior cached period?
Cached Foghorn Therapeutics Inc (FHTX) revenue was up 36.8% from $22.6M (Dec 31, 2024) to $30.9M (Dec 31, 2025). Statements: https://lician.com/financials/fhtx
Where are FHTX earnings listed?
Cached earnings facts for Foghorn Therapeutics Inc (FHTX) are listed at https://lician.com/earnings/fhtx. Statements: https://lician.com/financials/fhtx
Not investment advice.